Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Binge Eating Disorders01:23

Binge Eating Disorders

Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hormones, hormesis, and holistic obesity care.

JPMA. The Journal of the Pakistan Medical Association·2026
Same author

Baroneurosis.

JPMA. The Journal of the Pakistan Medical Association·2026
Same author

Baropsychology.

JPMA. The Journal of the Pakistan Medical Association·2026
Same author

Water and weight: the role of hydration in weight management.

JPMA. The Journal of the Pakistan Medical Association·2026
Same author

A quantum approach to the endocrinology of obesity.

Endocrine connections·2026
Same author

A Multidisciplinary Approach to Addressing Barriers in Osteoporosis Screening, Diagnosis, Therapy Sequencing, and Adherence in India.

Cureus·2026

Related Experiment Video

Updated: Jun 28, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Meta-Pharmacologic Support and Scaffolding for Obesity Therapy.

Sanjay Kalra1, Nitin Kapoor2, Saurabh Arora3

  • 1Department of Endocrinology, Bharti Hospital, Karnal, India; University Center for Research & Development, Chandigarh University, India.

JPMA. the Journal of the Pakistan Medical Association
|June 27, 2026
PubMed
Summary

Obesity treatment requires more than just medication. Comprehensive support, including medical, lifestyle, and psychosocial strategies, is essential for successful and sustained weight management alongside pharmacotherapy.

Keywords:
Holistic care, Lifestyle medicine, nonpharmacological care, overweight, obesity, person-centred care

More Related Videos

An Acupoint Catgut-embedding Therapy for Treating Obesity
04:50

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

Control of Eating Behavior Using a Novel Feedback System
04:48

Control of Eating Behavior Using a Novel Feedback System

Published on: May 8, 2018

Related Experiment Videos

Last Updated: Jun 28, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

An Acupoint Catgut-embedding Therapy for Treating Obesity
04:50

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

Control of Eating Behavior Using a Novel Feedback System
04:48

Control of Eating Behavior Using a Novel Feedback System

Published on: May 8, 2018

Area of Science:

  • Endocrinology
  • Metabolic Diseases
  • Pharmacology

Background:

  • Obesity is a complex endocrine disorder with significant health implications.
  • Emerging pharmacotherapies, such as hormone receptor modulators, offer new treatment avenues.
  • Pharmacotherapy alone is insufficient for managing obesity effectively.

Purpose of the Study:

  • To systematically review the essential non-pharmacological support strategies for obesity management.
  • To define and categorize these supportive measures as 'metapharmacologic'.
  • To emphasize the necessity of a multidimensional approach in conjunction with drug therapy.

Main Methods:

  • Systematic review and synthesis of existing literature on obesity management.
  • Categorization of supportive interventions into biomedical, lifestyle, and psychosocial domains.
  • Integration of metapharmacologic strategies with pharmacotherapeutic options.

Main Results:

  • Identified key metapharmacologic components crucial for optimizing obesity treatment outcomes.
  • Highlighted the interconnectedness of biomedical, lifestyle, and psychosocial factors.
  • Demonstrated that sustained success in obesity management relies on integrated, multidimensional support.

Conclusions:

  • Effective obesity management necessitates a comprehensive strategy beyond pharmacotherapy.
  • Metapharmacologic interventions encompassing biomedical, lifestyle, and psychosocial optimization are vital.
  • Integrated support systems are critical for achieving and maintaining therapeutic goals in obesity treatment.